精神分裂症内侧前额叶谷氨酸降低且受测量质量调节:质子磁共振波谱研究的荟萃分析
该荟萃分析纳入83个质子磁共振波谱数据集,其中36个数据集(2086名参与者)分析内侧前额叶谷氨酸,发现精神分裂症患者该区域谷氨酸显著降低(g=-0.19)。测量质量指标(CRLB和变异系数)显著调节该效应,高质量测量下降低更明显(g=-0.44或-0.43)。海马、丘脑和背外侧前额叶未见显著组间差异。
要点
- 精神分裂症患者内侧前额叶谷氨酸显著降低,效应量g=-0.19。
- CRLB和变异系数等测量质量指标显著调节谷氨酸降低效应。
- 高质量测量下内侧前额叶谷氨酸降低更明显(g=-0.44或-0.43)。
核心结论
- 高质量测量显示精神分裂症患者内侧前额叶谷氨酸 consistently 降低。
- 更严格的CRLB标准和减少干扰方差可能提高未来研究的敏感性。
研究设计与样本
- 通过检索既往荟萃分析和MEDLINE数据库,纳入83个质子磁共振波谱数据集(截至2020年3月25日)。
- 采用随机效应、逆方差加权模型计算合并效应量(Hedges' g),并分析测量质量指标等调节因素。
主要发现
- 在36个数据集(2086名参与者)中,患者内侧前额叶谷氨酸显著降低(g=-0.19,CI=-0.07至-0.32)。
- CRLB和变异系数质量亚组显著调节该效应,低CRLB或低变异系数研究中谷氨酸降低更明显(g=-0.44,CI=-0.29至-0.60;g=-0.43,CI=-0.29至-0.57)。
- 回波时间≤20 ms的研究也显示谷氨酸降低更显著(g=-0.41,CI=-0.26至-0.55)。
- 在11个海马数据集中,组间差异和调节效应均不显著;丘脑和背外侧前额叶的组效应也不显著。
关键数值与推荐
- 内侧前额叶谷氨酸降低的合并效应量g=-0.19(CI=-0.07至-0.32)。
- 低CRLB亚组g=-0.44(CI=-0.29至-0.60),低变异系数亚组g=-0.43(CI=-0.29至-0.57)。
- 回波时间≤20 ms亚组g=-0.41(CI=-0.26至-0.55)。
临床怎么用
- 临床解读精神分裂症谷氨酸波谱研究时需考虑测量质量指标(CRLB、变异系数)的影响。
- 未来研究可采用更严格CRLB标准和减少干扰方差以提高检测灵敏度。
局限性
- 海马、丘脑和背外侧前额叶的组间差异不显著,可能受样本量或测量质量限制。
- 未报告其他潜在调节因素(如药物、年龄、病程)的具体分析结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Magnetic resonance spectroscopy studies measuring brain glutamate separately from glutamine are helping elucidate schizophrenia pathophysiology. An expanded literature and improved methodologies motivate an updated meta-analysis examining effects of measurement quality and other moderating factors in characterizing abnormal glutamate levels in schizophrenia. METHODS: Searching previous meta-analyses and the MEDLINE database identified 83 proton magnetic resonance spectroscopy datasets published through March 25, 2020. Three quality metrics were extracted-Cramér-Rao lower bound (CRLB), line width, and coefficient of variation. Pooled effect sizes (Hedges' g) were calculated with random-effects, inverse variance-weighted models. Moderator analyses were conducted using quality metrics, field strength, echo time, medication, age, and stage of illness. RESULTS: Across 36 datasets (2086 participants), medial prefrontal cortex glutamate was significantly reduced in patients (g = -0.19, confidence interval [CI] = -0.07 to -0.32). CRLB and coefficient of variation quality subgroups significantly moderated this effect. Glutamate was significantly more reduced in studies with lower CRLB or coefficient of variation (g = -0.44, CI = -0.29 to -0.60, and g = -0.43, CI = -0.29 to -0.57, respectively). Studies using echo time ≤20 ms also showed significantly greater reduction in glutamate (g = -0.41, CI = -0.26 to -0.55). Across 11 hippocampal datasets, group differences and moderator effects were nonsignificant. Group effects in thalamus and dorsolateral prefrontal cortex were also nonsignificant. CONCLUSIONS: High-quality measurements reveal consistently reduced medial prefrontal cortex glutamate in schizophrenia. Stricter CRLB criteria and reduced nuisance variance may increase the sensitivity of future studies examining additional regions and the pathophysiological significance of abnormal glutamate levels in schizophrenia.
引用
- Smucny J, Carter CS, Maddock RJ, et al. Medial Prefrontal Cortex Glutamate Is Reduced in Schizophrenia and Moderated by Measurement Quality: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies. Biol Psychiatry. 2021. PMID: 34344534. doi:10.1016/j.biopsych.2021.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。